We are pleased to announce the launch of our Early Access Program for MiroSynth™ Cell-Free DNA, a new solution for producing highly accurate, linear double-stranded DNA, designed to support accelerated therapeutic development.
Learn more about our MiroSynth™ Cell-Free DNA Early Access Program on our dedicated program page.
